Prolonged-release Potassium Chloride Generics bulk supplier for pharma manufacturers

Prolonged-Release Potassium Chloride Generics Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)

Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)

Prolonged-release Potassium Chloride is an oral electrolyte supplement used to treat and prevent hypokalemia, especially in CKD and patients on diuretics, offering controlled potassium release for stable serum levels.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.

Prolonged-Release Potassium Chloride Generics — third party manufacturing & bulk supply

Prolonged-Release Potassium Chloride Generics is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Prolonged-Release Potassium Chloride Generics is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Prolonged-Release Potassium Chloride Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Prolonged-Release Potassium Chloride Gen... →

Back to Listing

Frequently Asked Questions

Prolonged-release Potassium Chloride Generics is listed as Tablet in 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Prolonged-release Potassium Chloride Generics is referenced against Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.